XML 46 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Values of Assets and Liabilities (Tables)
9 Months Ended
Sep. 30, 2013
Fair Value Disclosures [Abstract]  
Schedule of assets and liabilities measured at fair value on a recurring basis
The following tables present the balances of assets and liabilities of Ameriprise Financial measured at fair value on a recurring basis: 
 
September 30, 2013
  
 
Level 1
 
Level 2
 
Level 3
 
Total
  
 
(in millions)
  
Assets
 

 
 

 
 

 
 

  
Cash equivalents
$
19

 
$
2,375

 
$

 
$
2,394

  
Available-for-Sale securities:
 

 
 

 
 

 
 

  
Corporate debt securities

 
15,870

 
1,632

 
17,502

  
Residential mortgage backed securities

 
5,655

 
288

 
5,943

  
Commercial mortgage backed securities

 
2,755

 
15

 
2,770

  
Asset backed securities

 
1,222

 
203

 
1,425

  
State and municipal obligations

 
2,123

 

 
2,123

  
U.S. government and agencies obligations
17

 
36

 

 
53

  
Foreign government bonds and obligations

 
252

 

 
252

  
Common stocks
5

 
6

 
5

 
16

  
Total Available-for-Sale securities
22

 
27,919

 
2,143

 
30,084

  
Trading securities
3

 
23

 

 
26

  
Separate account assets

 
77,788

 

 
77,788

  
Other assets:
 
 
 
 
 
 
 
 
Interest rate derivative contracts

 
1,642

 

 
1,642

  
Equity derivative contracts
385

 
1,133

 

 
1,518

  
Foreign currency derivative contracts
1

 
2

 

 
3

  
Total other assets
386

 
2,777

 

 
3,163

  
Total assets at fair value
$
430

 
$
110,882

 
$
2,143

 
$
113,455

  
Liabilities
 
 
 
 
 
 
 
 
Future policy benefits:
 

 
 

 
 

 
 

  
EIA embedded derivatives
$

 
$
4

 
$

 
$
4

  
IUL embedded derivatives

 

 
96

 
96

  
GMWB and GMAB embedded derivatives

 

 
(256
)
 
(256
)
(2) 
Total future policy benefits

 
4

 
(160
)
 
(156
)
(1) 
Customer deposits

 
7

 

 
7

  
Other liabilities:
 

 
 

 
 

 
 

  
Interest rate derivative contracts

 
1,554

 

 
1,554

  
Equity derivative contracts
333

 
2,083

 

 
2,416

  
Credit derivative contracts

 
6

 

 
6

 
Foreign currency derivative contracts
1

 

 

 
1

  
Other

 
12

 

 
12

  
Total other liabilities
334

 
3,655

 

 
3,989

  
Total liabilities at fair value
$
334

 
$
3,666

 
$
(160
)
 
$
3,840

  
(1) The Company’s adjustment for nonperformance risk resulted in a $238 million cumulative increase to the embedded derivatives.
(2) The fair value of the GMWB and GMAB embedded derivatives was a net asset at September 30, 2013 and the amount is reported as a contra liability.

 
December 31, 2012
  
 
Level 1
 
Level 2
 
Level 3
 
Total
  
 
(in millions)
  
Assets
 

 
 

 
 

 
 

  
Cash equivalents
$
18

 
$
1,539

 
$

 
$
1,557

  
Available-for-Sale securities:
 

 
 

 
 

 
 

  
Corporate debt securities

 
17,051

 
1,764

 
18,815

  
Residential mortgage backed securities

 
5,145

 
284

 
5,429

  
Commercial mortgage backed securities

 
3,213

 
206

 
3,419

  
Asset backed securities

 
1,097

 
178

 
1,275

  
State and municipal obligations

 
2,239

 

 
2,239

  
U.S. government and agencies obligations
19

 
39

 

 
58

  
Foreign government bonds and obligations

 
224

 

 
224

  
Common stocks
3

 
4

 
6

 
13

  
Total Available-for-Sale securities
22

 
29,012

 
2,438

 
31,472

  
Trading securities
1

 
24

 

 
25

  
Separate account assets

 
72,397

 

 
72,397

  
Other assets:
 

 
 

 
 

 
 

  
Interest rate derivative contracts

 
2,358

 

 
2,358

  
Equity derivative contracts
285

 
973

 

 
1,258

  
Foreign currency derivative contracts

 
6

 

 
6

  
Commodity derivative contracts

 
1

 

 
1

  
Total other assets
285

 
3,338

 

 
3,623

  
Total assets at fair value
$
326

 
$
106,310

 
$
2,438

 
$
109,074

  
Liabilities
 

 
 

 
 

 
 

  
Future policy benefits:
 

 
 

 
 

 
 

  
EIA embedded derivatives
$

 
$
2

 
$

 
$
2

  
IUL embedded derivatives

 

 
45

 
45

  
GMWB and GMAB embedded derivatives

 

 
833

 
833

  
Total future policy benefits

 
2

 
878

 
880

(1) 
Customer deposits

 
8

 

 
8

  
Other liabilities:
 

 
 

 
 

 
 

  
Interest rate derivative contracts

 
1,486

 

 
1,486

  
Equity derivative contracts
258

 
1,565

 

 
1,823

  
Foreign currency derivative contracts
1

 

 

 
1

  
Other
1

 
3

 

 
4

  
Total other liabilities
260

 
3,054

 

 
3,314

  
Total liabilities at fair value
$
260

 
$
3,064

 
$
878

 
$
4,202

  
 
(1) The Company’s adjustment for nonperformance risk resulted in a $398 million cumulative decrease to the embedded derivatives.
Schedule of changes in level 3 assets and liabilities measured at fair value on a recurring basis
The following tables provide a summary of changes in Level 3 assets and liabilities of Ameriprise Financial measured at fair value on a recurring basis:
 
Available-for-Sale Securities
 
Future Policy Benefits
 
Corporate Debt Securities
 
Residential Mortgage Backed Securities
 
Commercial Mortgage Backed Securities
 
Asset Backed Securities
 
Common Stocks
 
Total
 
IUL Embedded Derivatives
 
GMWB and GMAB Embedded Derivatives
 
Total
 
(in millions)
Balance, July 1, 2013
$
1,667

 
$
69

 
$
210

 
$
214

 
$
5

 
$
2,165

 
$
(76
)
 
$
(11
)
 
$
(87
)
Total gains (losses) included in:
Net income
(1
)
 

 

 

 

 
(1
)
(1) 
(2
)
(2) 
322

(3) 
320

Other comprehensive income
3

 
(1
)
 

 
(2
)
 

 

 

 

 

Purchases

 
245

 

 
29

 

 
274

 

 

 

Sales

 

 

 

 

 

 

 

 

Issues

 

 

 

 

 

 
(17
)
 
(60
)
 
(77
)
Settlements
(37
)
 
(6
)
 
(36
)
 
(1
)
 

 
(80
)
 
(1
)
 
5

 
4

Transfers into Level 3

 

 

 

 

 

 

 

 

Transfers out of Level 3

 
(19
)
 
(159
)
 
(37
)
 

 
(215
)
 

 

 

Balance, September 30, 2013
$
1,632

 
$
288

 
$
15

 
$
203

 
$
5

 
$
2,143

 
$
(96
)
 
$
256

 
$
160

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Changes in unrealized gains (losses) relating to assets and liabilities held at September 30, 2013 included in:
Net investment income
$
(1
)
 
$

 
$

 
$
1

 
$

 
$

 
$

 
$

 
$

Interest credited to fixed accounts

 

 

 

 

 

 
(2
)
 

 
(2
)
Benefits, claims, losses and settlement expenses

 

 

 

 

 

 

 
321

 
321

(1) Included in net investment income in the Consolidated Statements of Operations.
(2) Included in interest credited to fixed accounts in the Consolidated Statements of Operations.
(3) Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Operations.

 
Available-for-Sale Securities
  
Future Policy Benefits
 
Corporate Debt Securities
 
Residential Mortgage Backed Securities
 
Commercial Mortgage Backed Securities
 
Asset Backed Securities
 
Common Stocks
 
Total
 
IUL Embedded Derivatives
 
GMWB and GMAB Embedded Derivatives
 
Total
 
(in millions)
Balance, July 1, 2012
$
1,485

 
$
238

 
$
69

 
$
185

 
$
5

 
$
1,982

  
$

 
$
(1,406
)
 
$
(1,406
)
Total gains (losses) included in:
Net income
(1
)
 
(31
)
 
1

 
1

 

 
(30
)
(1) 
1

(2) 
321

(3) 
322

Other comprehensive income
14

 
40

 
4

 
3

 

 
61

  

  

 

Purchases
139

 
54

 

 

 

 
193

  

  

 

Sales

 
(75
)
 

 

 

 
(75
)
  

  

 

Issues

 

 

 

 

 

 
(16
)
 
(49
)
 
(65
)
Settlements
(40
)
 
(8
)
 
(1
)
 
(4
)
 

 
(53
)
 

  
(8
)
 
(8
)
Transfers into Level 3

 

 
146

 
15

 

 
161

 
(22
)
  

 
(22
)
Transfers out of Level 3

 
(146
)
 
(7
)
 

 

 
(153
)
 

  

 

Balance, September 30, 2012
$
1,597

 
$
72

 
$
212

 
$
200

 
$
5

 
$
2,086

 
$
(37
)
 
$
(1,142
)
 
$
(1,179
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Changes in unrealized gains (losses) relating to assets and liabilities held at September 30, 2012 included in:
Net investment income
$
(1
)
 
$

 
$
1

 
$
1

 
$

 
1

 
$

 
$

 
$

Interest credited to fixed accounts

 

 

 

 

 

 
1

 

 
1

Benefits, claims, losses and settlement expenses

 

 

 

 

 

 

 
310

 
310

(1) Included in net investment income in the Consolidated Statements of Operations.
(2) Included in interest credited to fixed accounts in the Consolidated Statements of Operations.
(3) Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Operations.

 
Available-for-Sale Securities
 
Future Policy Benefits
 
Corporate Debt Securities
 
Residential Mortgage Backed Securities
 
Commercial Mortgage Backed Securities
 
Asset Backed Securities
 
Common Stocks
 
Total
 
IUL Embedded Derivatives
 
GMWB and GMAB Embedded Derivatives
 
Total
 
(in millions)
Balance, January 1, 2013
$
1,764

 
$
284

 
$
206

 
$
178

 
$
6

 
$
2,438

 
$
(45
)
 
$
(833
)
 
$
(878
)
Total gains (losses) included in:
Net income
(2
)
 

 

 
1

 

 
(1
)
(1) 
(8
)
(2) 
1,246

(3) 
1,238

Other comprehensive loss
(34
)
 
(1
)
 
(6
)
 
5

 

 
(36
)
 

 

  

Purchases
74

 
307

 
10

 
200

 

 
591

 

 

 

Sales

 

 

 

 

 

 

 

 

Issues

 

 

 

 

 

 
(42
)
 
(163
)
 
(205
)
Settlements
(170
)
 
(7
)
 
(36
)
 
(4
)
 

 
(217
)
 
(1
)
 
6

 
5

Transfers into Level 3

 

 

 
8

 

 
8

 

 

 

Transfers out of Level 3

 
(295
)
 
(159
)
 
(185
)
 
(1
)
 
(640
)
 

 

 

Balance, September 30, 2013
$
1,632

 
$
288

 
$
15

 
$
203

 
$
5

 
$
2,143

 
$
(96
)
 
$
256

 
$
160

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Changes in unrealized gains (losses) relating to assets and liabilities held at September 30, 2013 included in:
Net investment income
$
(2
)
 
$

 
$

 
$
1

 
$

 
$
(1
)
 
$

 
$

 
$

Interest credited to fixed accounts

 

 

 

 

 

 
(8
)
 

 
(8
)
Benefits, claims, losses and settlement expenses

 

 

 

 

 

 

 
1,229

 
1,229

(1) Included in net investment income in the Consolidated Statements of Operations.
(2) Included in interest credited to fixed accounts in the Consolidated Statements of Operations.
(3) Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Operations.
 

 
Available-for-Sale Securities
  
Future Policy Benefits
 
Corporate Debt Securities
 
Residential Mortgage Backed Securities
 
Commercial Mortgage Backed Securities
 
Asset Backed Securities
 
Common Stocks
 
Total
 
IUL Embedded Derivatives
 
GMWB and GMAB Embedded Derivatives
 
Total
 
(in millions)
Balance, January 1, 2012
$
1,355

 
$
215

 
$
50

 
$
189

 
$
5

 
$
1,814

 
$

 
$
(1,585
)
 
$
(1,585
)
Total gains (losses) included in:
Net income
(1
)
 
(45
)
 
1

 
2

 

 
(43
)
(1) 
1

(2) 
577

(3) 
578

Other comprehensive income
19

 
68

 
6

 
4

 

 
97

 

 

 

Purchases
349

 
99

 
9

 

 
1

 
458

 

 

 

Sales

 
(75
)
 

 

 

 
(75
)
 

 

 

Issues

 

 

 

 

 

 
(16
)
 
(131
)
 
(147
)
Settlements
(135
)
 
(38
)
 
(3
)
 
(17
)
 

 
(193
)
 

 
(3
)
 
(3
)
Transfers into Level 3
10

 
22

 
183

 
22

 

 
237

 
(22
)
 

 
(22
)
Transfers out of
Level 3

 
(174
)
 
(34
)
 

 
(1
)
 
(209
)
 

 

 

Balance, September 30, 2012
$
1,597

 
$
72

 
$
212

 
$
200

 
$
5

 
$
2,086

 
$
(37
)
 
$
(1,142
)
 
$
(1,179
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Changes in unrealized gains (losses) relating to assets and liabilities held at September 30, 2012 included in:
Net investment income
$
(1
)
 
$

 
$
1

 
$
1

 
$

 
$
1

 
$

 
$

 
$

Interest credited to fixed accounts

 

 

 

 

 

 
1

 

 
1

Benefits, claims, losses and settlement expenses

 

 

 

 

 

 

 
544

 
544

(1) Included in net investment income in the Consolidated Statements of Operations.
(2) Included in interest credited to fixed accounts in the Consolidated Statements of Operations.
(3) Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Operations.
Significant unobservable inputs used in the fair value measurements
The following tables provide a summary of the significant unobservable inputs used in the fair value measurements developed by the Company or reasonably available to the Company of Level 3 assets and liabilities:
 
September 30, 2013
 
Fair Value
 
Valuation 
Technique
 
Unobservable 
Input
 
Range 
 
Weighted Average
 
(in millions)
 
 
 
 
 
 
 
 
 
Corporate debt securities (private placements)
$
1,583

 
Discounted cash flow
 
Yield/spread to U.S. Treasuries
 
1.0
%
5.5%
 
1.8%
IUL embedded derivatives
$
96

 
Discounted cash flow
 
Nonperformance risk (3)
 
95

 
bps
 
 
GMWB and GMAB embedded derivatives
$
(256
)
 
Discounted cash flow
 
Utilization of guaranteed withdrawals (1)
 
0.0
%
51.1%
 
 
 
 
 
 
 
Surrender rate
 
0.1
%
57.9%
 
 
 
 

 
 
 
Market volatility (2)
 
5.1
%
19.1%
 
 
 
 
 
 
 
Nonperformance risk (3)
 
95

 
bps
 
 
 
 
 
 
 
Elective contractholder strategy allocations (4)
 
0.0
%
50.0%
 
 
 
 
December 31, 2012
 
Fair Value
 
Valuation 
Technique
 
Unobservable 
Input
 
Range 
 
Weighted Average
 
(in millions)
 
 
 
 
 
 
 
 
 
Corporate debt securities (private placements)
$
1,712

 
Discounted cash flow
 
Yield/spread to U.S. Treasuries
 
1.1
%
8.5%
 
2.1%
IUL embedded derivatives
$
45

 
Discounted cash flow
 
Nonperformance risk (3)
 
97

 
bps
 
 
GMWB and GMAB embedded derivatives
$
833

 
Discounted cash flow
 
Utilization of guaranteed withdrawals (1)
 
0.0
%
56.4%
 
 
 
 
 
 
 
Surrender rate
 
0.0
%
56.3%
 
 
 
 

 
 
 
Market volatility (2)
 
5.6
%
21.2%
 
 
 
 
 
 
 
Nonperformance risk (3)
 
97

 
bps
 
 
(1) The utilization of guaranteed withdrawals represents the percentage of policyholders that will begin withdrawing in any given year.
(2) Market volatility is implied volatility of fund of funds and portfolio stabilizer funds.
(3) The nonperformance risk is the spread added to the observable interest rates used in the valuation of the embedded derivatives.
(4) The elective allocation represents the percentage of contractholders that are assumed to electively switch their investment allocation to a different allocation model.
Schedule of carrying value and estimated fair value of financial instruments
The following tables provide the carrying value and the estimated fair value of financial instruments that are not reported at fair value. All other financial instruments that are reported at fair value have been included above in the table with balances of assets and liabilities Ameriprise Financial measured at fair value on a recurring basis.
 
September 30, 2013
 
Carrying Value
 
Fair Value
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
(in millions)
Financial Assets
 

 
 

 
 

 
 

 
 

Mortgage loans, net
$
3,524

 
$

 
$

 
$
3,544

 
$
3,544

Policy and certificate loans
769

 

 
1

 
756

 
757

Receivables
1,092

 
95

 
989

 
8

 
1,092

Restricted and segregated cash
2,259

 
2,259

 

 

 
2,259

Other investments and assets
362

 

 
294

 
69

 
363

 
 
 
 
 
 
 
 
 
 
Financial Liabilities
 

 
 

 
 

 
 

 
 

Policyholder account balances, future policy benefits and claims
$
14,283

 
$

 
$

 
$
14,853

 
$
14,853

Investment certificate reserves
3,869

 

 

 
3,878

 
3,878

Brokerage customer deposits
2,868

 
2,868

 

 

 
2,868

Separate account liabilities
3,654

 

 
3,654

 

 
3,654

Debt and other liabilities
3,554

 
131

 
3,632

 
82

 
3,845

 
 
December 31, 2012
 
Carrying Value
 
Fair Value
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
(in millions)
Financial Assets
 

 
 

 
 

 
 

 
 

Mortgage loans, net
$
3,609

 
$

 
$

 
$
3,694

 
$
3,694

Policy and certificate loans
754

 

 
2

 
725

 
727

Receivables
1,067

 
135

 
926

 
12

 
1,073

Restricted and segregated cash
2,538

 
2,538

 

 

 
2,538

Other investments and assets
390

 

 
333

 
60

 
393

 
 
 
 
 
 
 
 
 
 
Financial Liabilities
 

 
 

 
 

 
 

 
 

Policyholder account balances, future policy benefits and claims
$
14,701

 
$

 
$

 
$
15,982

 
$
15,982

Investment certificate reserves
3,494

 

 

 
3,494

 
3,494

Brokerage customer deposits
3,024

 
3,024

 

 

 
3,024

Separate account liabilities
3,362

 

 
3,362

 

 
3,362

Debt and other liabilities
3,033

 
145

 
3,109

 
142

 
3,396